Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood Schistosoma mansoni–Associated Morbidity: A Combined Analysis from the Schistosomiasis Consortium for Operational Research and Evaluation Cohort Studies in the Lake Victoria Regions of Kenya and Tanzania

The WHO recommends mass treatment with praziquantel as the primary approach for Schistosoma mansoni–related morbidity control in endemic populations. The Schistosomiasis Consortium for Operational Research and Evaluation implemented multi-country, cluster-randomized trials to compare effectiveness o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Ye, Wiegand, Ryan E., Olsen, Annette, King, Charles H., Kittur, Nupur, Binder, Sue, Zhang, Feng, Whalen, Christopher C., Secor, William Evan, Montgomery, Susan P., Mwinzi, Pauline N. M., Magnussen, Pascal, Kinung’hi, Safari, Campbell, Carl H., Colley, Daniel G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896894/
https://www.ncbi.nlm.nih.gov/pubmed/31407653
http://dx.doi.org/10.4269/ajtmh.19-0273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896894/
https://www.ncbi.nlm.nih.gov/pubmed/31407653
http://dx.doi.org/10.4269/ajtmh.19-0273

Ejemplares similares